Fluidigm (United States)

Fluidigm (United States)

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Fluidigm (United States), United States, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

57%


Total
Publications

371


Total Open
Publications

210


Total
Citations

31K


Open Access
Percentage

57%


Total
Publications

371


Total Open
Publications

210


Total
Citations

31K

Wikipedia

Website

download

Breakdown

10% 33% 13% 44%

Publisher Open

10%

Both

33%

Other Platform Open

13%

Closed

44%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

59%OA Journal

OA Journal 59%

93

Hybrid 19%

30

No Guarantees 22%

35

Other Platform Open

Domain 78%

132

Institution 39%

67

Other Internet 22%

37

Preprint 10%

17

Public 7%

12

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
132
doaj.org OAI-PMH Repository
Institution
45
DOI
Other Internet
35
bioRxiv
Preprint
14
Figshare
Public
10
Europe PMC
Domain
7
Office of Scientific and Technical Information
Institution
6
University of British Columbia
Institution
4
Royal Netherlands Academy of Arts and Sciences
Institution
4
Massachusetts Institute of Technology
Institution
4
1 / 4

Data updated 12 August 2026

Share

Share

Share